Transcat, Inc. (TRNS)
Stock Price Chart
Key Info
| Market Cap | 200.83M |
| Revenue (ttm) | 169.61M |
| Net Income (ttm) | 7.15M |
| Shares Out | 7.41M |
| EPS (ttm) | 0.96 |
| PE Ratio | 28.22 |
| Forward PE | 33.44 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 23, 2020 |
| Last Price | $27.09 |
| Previous Close | $27.41 |
| Change ($) | -0.32 |
| Change (%) | -1.17% |
| Day's Open | 27.42 |
| Day's Range | 26.75 - 27.96 |
| Day's Volume | 18,202 |
| 52-Week Range | 16.50 - 34.18 |
More Stats
| Market Cap | 200.83M |
| Enterprise Value | 235.53M |
| Earnings Date (est) | Oct 27, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 7.41M |
| Float | 6.87M |
| EPS (basic) | 0.97 |
| EPS (diluted) | 0.96 |
| FCF / Share | 1.13 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 3.54% |
| FCF Yield | 4.15% |
| Payout Ratio | n/a |
| Shares Short | 55,276 |
| Short Ratio | 1.99 |
| Short % of Float | 0.81% |
| Beta | 0.72 |
| PE Ratio | 28.22 |
| Forward PE | 33.44 |
| P/FCF Ratio | 24.10 |
| PS Ratio | 1.18 |
| PB Ratio | 3.01 |
| Revenue | 169.61M |
| Operating Income | 9.86M |
| Net Income | 7.15M |
| Free Cash Flow | 8.34M |
| Net Cash | -34.70M |
| Net Cash / Share | -4.68 |
| Gross Margin | 25.04% |
| Operating Margin | 5.81% |
| Profit Margin | 4.20% |
| FCF Margin | 4.91% |
| ROA | 5.37% |
| ROE | 11.15% |
| ROIC | 11.10% |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 173 | 161 | 155 | 144 | 122 | 124 | 119 | 112 | 110 | 91.19 |
| Revenue Growth | 7.58% | 3.71% | 7.81% | 17.79% | -1.18% | 4.32% | 5.53% | 2.07% | 20.65% | - |
| Gross Profit | 42.48 | 39.34 | 37.44 | 34.97 | 29.12 | 29.09 | 29.79 | 27.40 | 27.12 | 23.30 |
| Operating Income | 10.85 | 10.23 | 9.03 | 7.93 | 6.30 | 6.77 | 6.71 | 5.95 | 5.43 | 4.59 |
| Net Income | 8.07 | 7.15 | 5.92 | 4.52 | 4.12 | 4.03 | 3.98 | 3.70 | 3.30 | 2.79 |
| Shares Outstanding | 7.33 | 7.20 | 7.12 | 6.99 | 6.89 | 6.80 | 7.08 | 7.40 | 7.31 | 7.29 |
| Earnings Per Share | 1.08 | 0.95 | 0.81 | 0.64 | 0.58 | 0.57 | 0.54 | 0.49 | 0.43 | 0.37 |
| EPS Growth | 13.68% | 17.28% | 26.56% | 10.34% | 1.75% | 5.56% | 10.2% | 13.95% | 16.22% | - |
| Operating Cash Flow | 11.56 | 12.56 | 9.87 | 7.54 | 10.98 | 4.44 | 7.61 | 5.24 | 6.26 | 2.57 |
| Capital Expenditures | -6.40 | -6.98 | -5.87 | -5.19 | -4.07 | -3.45 | -1.71 | -2.66 | -1.39 | -1.65 |
| Free Cash Flow | 5.17 | 5.58 | 4.00 | 2.35 | 6.91 | 0.99 | 5.90 | 2.58 | 4.87 | 0.93 |
| Cash & Equivalents | 0.50 | 0.79 | 0.58 | 0.84 | 0.64 | 0.07 | 0.02 | 0.41 | 0.03 | 0.03 |
| Total Debt | 37.18 | 21.00 | 22.85 | 27.31 | 19.07 | 12.17 | 7.59 | 8.02 | 3.37 | 5.25 |
| Net Cash / Debt | -36.68 | -20.21 | -22.27 | -26.47 | -18.43 | -12.10 | -7.57 | -7.61 | -3.33 | -5.22 |
| Assets | 128 | 105 | 96.82 | 92.10 | 76.71 | 62.15 | 53.87 | 55.05 | 44.98 | 41.36 |
| Liabilities | 61.04 | 45.60 | 45.47 | 48.70 | 37.80 | 27.83 | 23.79 | 23.40 | 17.60 | 18.03 |
| Book Value | 67.09 | 59.63 | 51.35 | 43.40 | 38.91 | 34.32 | 30.08 | 31.65 | 27.38 | 23.33 |
Company Profile
Company Details
| Full Name | Transcat, Inc. |
| Country | United States |
| Employees | 722 |
| CEO | Lee D. Rudow |
Stock Information
| Ticker Symbol | TRNS |
| Stock Exchange | NASDAQ |
| Sector | Industrials |
| Industry | Industrial Distribution |
| Unique Identifier | NASDAQ: TRNS |
Description
Transcat provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with Web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, oil and gas and alternative energy, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.